Sirolimus-tacrolimus Combination Immunosuppression

Authors

Vivian C. McAlister, Queen Elizabeth II Health Sciences Centre, Halifax, NS
Zuhua Gao, Queen Elizabeth II Health Sciences Centre, Halifax, NS
Kevork Peltekian, Queen Elizabeth II Health Sciences Centre, Halifax, NS
Javier Domingues, Queen Elizabeth II Health Sciences Centre, Halifax, NS
Kamrar Mahalati, Queen Elizabeth II Health Sciences Centre, Halifax, NS
Allan S. MacDonald, Queen Elizabeth II Health Sciences Centre, Halifax, NS

Document Type

Article

Publication Date

1-29-2000

Journal

The Lancet

Volume

355

Issue

9201

First Page

376

Last Page

377

URL with Digital Object Identifier

http://dx.doi.org/10.1016/S0140-6736(99)03882-9

Abstract

A series of 32 recipients of liver, kidney, or pancreas transplants who were treated with sirolimus and low-dose tacrolimus experienced a low rate of rejection and excellent graft function without drug-related toxic effects.

Notes

Dr. Vivian McAlister is currently a faculty member at The University of Western Ontario.